Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5- α -Reductase in the Treatment of Androgenetic Alopecia

Prager, Nelson, Bickett, Karen, French, Nita, Marcovici, Geno·2002·The Journal of Alternative and Complementary Medicine

Abstract

BACKGROUND: Androgenetic alopecia (AGA) is characterized by the structural miniaturization of androgen-sensitive hair follicles in susceptible individuals and is anatomically defined within a given pattern of the scalp. Biochemically, one contributing factor of this disorder is the conversion of testosterone (T) to dihydrotestosterone (DHT) via the enzyme 5-alpha reductase (5AR). This metabolism is also key to the onset and progression of benign prostatic hyperplasia (BPH). Furthermore, AGA has also been shown to be responsive to drugs and agents used to treat BPH. Of note, certain botanical compounds have previously demonstrated efficacy against BPH. Here, we report the first example of a placebo-controlled, double-blind study undertaken in order to examine the benefit of these botanical substances in the treatment of AGA. OBJECTIVES: The goal of this study was to test botanically derived 5AR inhibitors, specifically the liposterolic extract of Serenoa repens (LSESr) and beta-sitosterol, in the treatment of AGA. SUBJECTS: Included in this study were males between the ages of 23 and 64 years of age, in good health, with mild to moderate AGA. RESULTS: The results of this pilot study showed a highly positive response to treatment. The blinded investigative staff assessment report showed that 60% of (6/10) study subjects dosed with the active study formulation were rated as improved at the final visit. CONCLUSIONS: This study establishes the effectiveness of naturally occurring 5AR inhibitors against AGA for the first time, and justifies the expansion to larger trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/107555302317371433

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 30

  1. 10.1007/s001200050061 · doi:10.1007/s001200050061
  2. 10.1002/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.3.CO;2-R · doi:10.1002/(sici)1097-0045(199610)29:4<231::aid-pros4>3.3.co;2-r
  3. 10.1016/0960-0760(94)90074-4 · DOI
  4. Gerber G, 2000, Health News, 6, 10
  5. 10.1016/S0090-4295(98)00143-5 · DOI
  6. 10.1210/jc.85.8.2913 · doi:10.1210/jc.85.8.2913 · Paper page
  7. 10.1016/S0149-2918(99)80052-6 · doi:10.1016/s0149-2918(99)80052-6
  8. 10.1016/0960-0760(95)00134-L · DOI
  9. 10.1210/jcem-70-3-777 · DOI
  10. 10.1016/S0149-2918(96)80180-9 · doi:10.1016/s0149-2918(96)80180-9
  11. 10.1001/archderm.135.8.989 · doi:10.1001/archderm.135.8.989
  12. Klepser TB, 1999, Am J Health Syst Pharm, 56, 125, 10.1093/ajhp/56.2.125 · DOI · Paper page
  13. 10.1093/jnci/92.1.42 · DOI · Paper page
  14. 10.1590/S0104-42301999000400014 · doi:10.1590/s0104-42301999000400014
  15. 10.1016/S0090-4295(99)00372-6 · doi:10.1016/s0090-4295(99)00372-6
  16. 10.1159/000020005 · doi:10.1159/000020005
  17. 10.1159/000134362 · doi:10.1159/000134362
  18. 10.1210/jcem-56-6-1209 · DOI
  19. 10.1002/(SICI)1097-0045(19991201)41:4<224::AID-PROS2>3.3.CO;2-H · doi:10.1002/(sici)1097-0045(19991201)41:4<224::aid-pros2>3.3.co;2-h
  20. 10.1111/j.1365-2230.1989.tb00881.x · doi:10.1111/j.1365-2230.1989.tb00881.x
  21. Shapiro J, 2000, Can Fam Phys, 46, 1469
  22. Schilcher H, 1999, Wien Med Wochenschr, 149, 236
  23. Swoboda H, 1999, Wien Med Wochenschr, 149, 235
  24. 10.1016/S0024-3205(99)00253-2 · DOI · Paper page
  25. 10.1210/jc.84.12.4324 · doi:10.1210/jc.84.12.4324
  26. Wilt T, 2000, Cochrane Database Syst Rev, 2, D001423
  27. Wilt T, 2000, Cochrane Database Syst Rev, 2, D001042
  28. 10.1046/j.1464-410x.1999.00026.x · DOI
  29. 10.1001/jama.280.18.1604 · DOI · Paper page
  30. Wolff H, 1999, MMW Fortschr Med, 141, 38

Cited by

See all 170

Metadata

Authors
Prager, N., Bickett, K., French, N., & Marcovici, G.
Venue
The Journal of Alternative and Complementary Medicine
Published
2002-04
Volume
8
Issue
2
Pages
143-152
ISSN
  • 1075-5535 (ISSN-L)
  • 1557-7708
OpenAlex
W2129911891
Cited by
170
References
3
FWCI
1.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5- α -Reductase in the Treatment of Androgenetic Alopecia. https://app.cochat.ai/papers/10.1089/107555302317371433
The paper
Prager, N., Bickett, K., French, N., & Marcovici, G. (2002). A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5- α -Reductase in the Treatment of Androgenetic Alopecia. The Journal of Alternative and Complementary Medicine. https://doi.org/10.1089/107555302317371433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.